Intelligence · Drug directory

Pipeline & Investigational Drugs

Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

Quick answer

Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

1,610 drugs · Pipeline · by data quality · Page 14 of 68

  1. diltiazem

    CARDIZEM Sanofi-aventis Healthcare Pty Ltd

    TGA: approved · NMPA: clinical trials

  2. diphenoxylate + atropine sulfate

    LOFENOXAL Lacuna Pharma Pty Ltd

    TGA: approved

  3. diphtheria + tetanus vaccine

    ADT BOOSTER Seqirus (Australia) Pty Ltd

    TGA: approved

  4. disopyramide

    RYTHMODAN (UK) Lacuna Pharma Pty Ltd

    TGA: approved

  5. docusate

    WAXSOL Lacuna Pharma Pty Ltd

    TGA: approved

  6. docusate + sennoside b

    CO-SENNA Lacuna Pharma Pty Ltd

    TGA: approved

  7. dolutegravir + abacavir + lamivudine

    TRIUMEQ ViiV Healthcare Pty Ltd

    TGA: approved

  8. dolutegravir + lamivudine

    DOVATO ViiV Healthcare Pty Ltd

    TGA: approved

  9. dolutegravir + rilpivirine

    JULUCA ViiV Healthcare Pty Ltd

    TGA: approved

  10. domperidone

    APO-DOMPERIDONE Apotex Pty Ltd

    TGA: approved

  11. donepezil

    ARICEPT Pfizer Australia Pty Ltd

    TGA: approved

  12. dorzolamide

    TRUSOPT Alphapharm Pty Ltd

    TGA: approved

  13. dorzolamide + timolol

    COSDOR Alphapharm Pty Ltd

    TGA: approved

  14. dosulepin

    DOSULEPIN VIATRIS Alphapharm Pty Ltd

    TGA: approved

  15. doxorubicin hydrochloride (as pegylated liposomal)

    CAELYX BAXTER HEALTHCARE PTY LTD

    TGA: approved

  16. drospirenone + ethinylestradiol

    YAZ Lacuna Pharma Pty Ltd

    TGA: approved

  17. dutasteride + tamsulosin

    DUODART 500UG/400UG GlaxoSmithKline

    TGA: approved

  18. eletriptan

    RELPAX Viatris Pharmaceuticals Co.,

    TGA: approved

  19. empagliflozin + linagliptin

    GLYXAMBI Boehringer Ingelheim Pty Ltd

    TGA: approved

  20. empagliflozin + metformin

    JARDIAMET 5 MG/500 MG Boehringer Ingelheim Pty Ltd

    TGA: approved

  21. emtricitabine + rilpivirine + tenofovir alafenamide

    ODEFSEY Gilead Sciences Pty Limited

    TGA: approved

  22. emtricitabine + tenofovir alafenamide

    DESCOVY Gilead Sciences Pty Limited

    TGA: approved

  23. enalapril

    ACETEC Alphapharm Pty Ltd

    TGA: approved · NMPA: clinical trials

  24. enalapril + hydrochlorothiazide

    RENITEC PLUS 20/6 Alphapharm Pty Ltd

    TGA: approved

Frequently asked questions

How many pipeline drugs are listed?

1,610 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.